BCL2 and cancer: Dysregulation of genes BCL-2 (B-cell CLL/lymphoma 2), DACH1 (Dachshund1), and THSD4 (Thrombospondin, type I domain containing 4) occur in the main processes of cancer progression that are controlled by GATA-3 (20).